ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



The beneficial effects of thymoquinone on viability and differentiation of human adipose tissue-derived mesenchymal stem cells

Ahsen Erginsoy, Nur Seda Gokdemir, Venhar Cinar, Eda Koseoglu, Zeynep Burcin Gonen, Tuba Dilay Kokenek Unal.



Abstract
Download PDF Post

Thymoquinone is the primary active substance extracted from Nigella sativa. It has been reported to have many beneficial and protective effects on several cell types. However, there are limited studies about its effects on mesenchymal stem cells (MSCs). The purpose of this study is to investigate the effect of thymoquinone on the cell viability, proliferation, and differentiation of MSCs obtained from human adipose tissue. MSCs were obtained from the biobank and treated with concentrations of 50 nM, 100 nM, 200 nM, and 300 nM thymoquinone. Cell viability, proliferation, and apoptosis analysis were performed. The effects of thymoquinone on the differentiation of human adipose tissue-derived mesenchymal stem cells (haMSCs) were investigated through adipogenic, osteogenic, and chondrogenic assays. As a result of our study, doses of 50 nM, 100 nM, 200 nM, and 300 nM thymoquinone have been demonstrated to enhance cell proliferation, prevent apoptosis, and contribute to adipogenic, chondrogenic, and osteogenic differentiation. Thymoquinone promotes the viability of haMSCs and induces differentiation into osteogenic, adipogenic, and chondrogenic lienages. Therefore, it is an auxiliary active ingredient that can be used safely in regenerative medicine.

Key words: Thymoquinone, cell differentiation, human adipose tissue-derived mesenchymal stem cell







Bibliomed Article Statistics

23
29
15
24
31
33
20
18
28
25
42
13
R
E
A
D
S

16

8

27

18

16

17

14

14

20

23

12

3
D
O
W
N
L
O
A
D
S
120102030405091011120102
202420252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.